Showing results (781-790 of 3,636) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|February 2, 2010
Positive progesterone receptors and cell proliferation index: an independent association with breast cancer in malesAntonio Piñero, Belén Ferri, Luis Polo, et al.Breast (Edinburgh, Scotland)|February 2, 2010
Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: a pathological and immunohistochemical studyL M Bacchi, M Corpa, P P Santos, et al.Breast (Edinburgh, Scotland)|April 25, 2022
Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancerAline Van der Vorst, Isabelle Kindts, Annouschka Laenen, et al.Breast (Edinburgh, Scotland)|April 24, 2022
Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysisNeha Pathak, Aparna Sharma, Arunmozhimaran Elavarasi, et al.Breast (Edinburgh, Scotland)|August 25, 2020
Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional studyJinfei Ma, Emmanuel Eric Pazo, Zihao Zou, et al.Breast (Edinburgh, Scotland)|March 28, 2021
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survivalFei Peng, Jingwen Li, Shidai Mu, et al.Breast (Edinburgh, Scotland)|March 28, 2021
Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrenceYang Li, Yixuan Song, Ronggang Lang, et al.Breast (Edinburgh, Scotland)|April 8, 2021
Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort studyChristel Jm de Blok, Benthe Am Dijkman, Chantal M Wiepjes, et al.Breast (Edinburgh, Scotland)|March 29, 2021
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumabRita De Sanctis, Laura Giordano, Federica D'Antonio, et al.Breast (Edinburgh, Scotland)|April 23, 2021
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trialHope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, et al.Pageof 364